SDSergey Vladimirovich Dolinny

Sergey Vladimirovich Dolinny

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sergey Vladimirovich Dolinny has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A clinical case of primary diagnosis of the quadricuspid aortic valve in the practice of a functional diagnostic physician

    by D. L. Dolinnaya, A. R. Tagirova, A. V. Stepanov, S. V. Dolinnyi, V. S. Bednova, E. S. Zharkova, N. F. Beresten, S. B. Tkachenko

    The quadricuspid aortic valve (QAV) is a rare congenital heart anomaly that can remain asymptomatic for a long time. Modern non-invasive imaging methods significantly shift the timing of diagnosis and allow for the identification of such patients at earlier stages and their adequate monitoring.

  • Express method for determining the sensitivity of pathogens of bacterial complications in COVID-19 to bacteriophages

    by Lyudmila Alexandrovna Kraeva, Lidiya Sergeevna Konkova, Olga Alexandrovna Burgasova, Sergey Vladimirovich Dolinny

    BACKGROUND: In recent years, there has been a catastrophic increase in the resistance of bacterial strains to antibacterial drugs. The spread of the novel coronavirus disease (COVID-19) pandemic has led to the overuse of antibiotics, which has led to an even greater spread of resistant strains in hospitals. Given the accumulated positive experience in using bacteriophages, it is advisable to use them in patients after determining the sensitivity of each strain of isolated bacteria to bacteriophages. Since Klebsiella pneumoniae was the most frequently isolated bacteria in complicated forms of COVID-19, it became necessary to determine the sensitivity of these and other gram-negative bacteria to the corresponding bacteriophages. AIM: This study aims to reduce the time for determining the sensitivity of an isolated microorganism culture to bacteriophages by developing an express method. MATERIALS AND METHODS: The study used 30 strains of pan-resistant Gram-negative microorganisms from the collection of the Museum of the Laboratory of Medical Bacteriology of the Pasteur Research Institute of Epidemiology and Microbiology in St. Petersburg: Klebsiella pneumoniae (n=10), Escherichia coli (n=10), Pseudomonas aeruginosa (n=10), and also preparations of bacteriophages manufactured by JSC NPO Microgen: Bacteriophage Klebsiella polyvalent purified; Bacteriophage coliproteus; Pseudomonas aeruginosa bacteriophage. RESULTS: Of the strains studied, 4 out of 10 studied K. pneumoniae strains, 6 out of 10 E. coli strains, and 7 out of 10 P. aeruginosa strains were susceptible to polyvalent bacteriophage preparations. Reliable results were obtained 3 hours after the sensitivity of isolated cultures to bacteriophages was established, which is undoubtedly the most important finding of the study. CONCLUSION: The developed method for determining the sensitivity of gram-negative bacteria to bacteriophages enables reducing the study time by 6 times (up to 3 hours), which affects the timing of etiotropic therapy selection with bacteriophages for each patient.

  • Characteristics of hypervirulent multi-drug resistant Klebsiella pneumoniae strains in inpatients with severe COVID-19

    by D.V. Azarov, A.S. Mokhov, A.A. Pochtovyi, D.D. Kustova, V.A. Gushchin, E.A. Lebedeva, V.V. Kolodzhieva, A.G. Kireeva, L.A. Kraeva, S.V. Dolinny, et al.

    Severe course of COVID-19 in inpatients can be caused by a number of reasons, including viral and bacterial superinfections. Empirical use of antibiotics, as well as poor infectious control stimulate the emergence and spread of multidrug-resistant bacteria. Klebsiella pneumoniae is the most common carbapenemase-producing bacterial pathogen causing nosocomial infections. These strains became significantly widespread during the COVID-19 pandemic. Objective. To analyze phenotypic and genetic characteristics of K. pneumoniae strains as the dominant bacterial pathogen in severe COVID-19 patients in the intensive care unit. Patients and methods. This study included 38 COVID-19 patients (including 6 patients with severe disease) treated in the intensive care units of Moscow and Saint Petersburg hospitals for infectious diseases between July 2020 and December 2020. All patients signed an informed consent to participate in the study; patient data was anonymized. The following samples were collected: sputum, bronchoalveolar lavage, and nasopharyngeal swabs. We performed bacteriological identification of isolated bacterial strains, drug susceptibility testing, and whole genome sequencing of K. pneumoniae strains. Results. The majority of K. pneumoniae strains isolated from patients with severe COVID-19 contained clusters of aerobactin and enterobacterin genes. However, some of them (strains 90 and 124) also contained clusters of yersiniabactin genes. These genes are associated with high virulence and ability to form biofilms. The isolated strains belonged to four sequence types (ST874, ST395, ST147, ST15) that are characterized by high virulence and antibiotic resistance. These K. pneumoniae strains can be considered as one of the major causes of severe and lethal COVID-19. Conclusion. Our findings suggest that the detection rate of K. pneumoniae in COVID-19 patients increased from 30% to 70% during the pandemic. Phenotypic tests demonstrated that more than 80% of the strains were resistant to most antibiotics used in patients with complicated COVID-19. The combination of gypervirulence and antibiotic resistance is crucial for nosocomial transmission of these strains and their effect on the disease outcome. The emergence of hyper-resistant pathogens necessitates regular epidemiological monitoring and robust infection control in Russian hospitals, especially in intensive care units. Key words: COVID-19, severe disease, Klebsiella pneumoniae, genome sequencing, carbapenemases, hypervirulence, antibiotic resistance